▁There 5.83203125
▁is 1.626953125
▁currently 4.72265625
▁a 1.4619140625
▁severe 5.44140625
▁lack 2.92578125
▁of 0.0206146240234375
▁information 3.65625
▁about 1.4462890625
▁the 0.7919921875
▁effects 3.875
▁of 0.1082763671875
▁op 6.61328125
i 3.775390625
ates 0.028350830078125
. 3.91015625
▁They 5.02734375
▁manage 9.1875
▁pain 2.126953125
▁successfully 6.66796875
, 1.00390625
▁but 0.283447265625
▁the 2.6328125
▁past 8.8984375
▁few 1.150390625
▁dec 1.5859375
ades 3.6597251892089844e-05
▁indicated 9.8828125
▁the 2.80859375
▁growing 3.595703125
▁concern 3.19140625
▁regarding 3.37109375
▁op 1.9833984375
iate 0.40185546875
▁ab 1.3798828125
use 0.0094146728515625
▁in 3.419921875
▁forms 9.8515625
▁of 0.2381591796875
▁over 3.35546875
d 0.0738525390625
ose 0.31982421875
▁and 0.79541015625
▁add 0.52490234375
iction 0.01433563232421875
. 0.09808349609375
▁A 4.12890625
▁more 5.3828125
▁manage 9.1015625
able 0.00284576416015625
▁and 2.099609375
▁sa 2.26171875
fer 0.0001596212387084961
▁alternative 1.9326171875
▁might 4.98046875
▁be 0.2481689453125
▁medical 5.8203125
▁mar 0.386474609375
iju 0.0010805130004882812
ana 4.756450653076172e-05
. 0.61962890625
▁However 4.3359375
, 0.0156707763671875
▁the 1.8798828125
▁legal 3.5546875
▁status 1.0693359375
▁and 3.41015625
▁novel 10.4609375
ty 0.212646484375
▁of 0.1463623046875
▁this 1.8681640625
▁drug 1.962890625
▁do 4.91796875
▁not 0.0391845703125
▁allow 0.98291015625
▁finding 7.9765625
▁a 2.63671875
▁large 3.37890625
▁number 0.97216796875
▁of 0.004169464111328125
▁studies 0.923828125
▁on 1.787109375
▁its 1.1279296875
▁effect 2.193359375
iveness 0.181640625
. 0.6806640625
▁Specifically 8.984375
, 0.08868408203125
▁it 2.787109375
▁concerns 5.34375
▁the 0.99365234375
▁emot 9.828125
ional 0.0372314453125
▁condition 5.36328125
▁of 0.623046875
▁patients 1.1826171875
▁experien 6.1328125
cing 9.5367431640625e-05
▁chron 1.0595703125
ic 0.0005893707275390625
▁pain 0.08697509765625
. 0.386474609375
▁This 3.044921875
▁research 2.75390625
▁paper 2.28125
▁a 1.650390625
ims 0.0002751350402832031
▁to 0.128662109375
▁analyze 2.8046875
▁levels 10.6796875
▁of 0.037017822265625
▁de 1.8427734375
pression 0.055816650390625
▁and 0.67919921875
▁anx 0.1328125
iety 0.0002694129943847656
▁among 1.494140625
▁people 2.515625
▁receiving 4.2109375
▁ther 4.98046875
apy 0.0355224609375
▁by 4.61328125
▁comparing 10.3046875
▁the 1.875
▁effects 2.451171875
▁of 0.0289154052734375
▁ph 5.6328125
arma 0.354736328125
ce 0.01131439208984375
ut 0.0002663135528564453
ical 0.0173492431640625
▁op 1.4140625
io 2.65625
ids 0.09234619140625
▁and 0.501953125
▁MM 4.1953125
. 2.421875
<0x0A> 0.3994140625
Chr 4.12109375
onic 0.00745391845703125
▁pain 0.141845703125
▁is 0.876953125
▁still 6.37890625
▁considered 3.005859375
▁to 1.7548828125
▁be 0.039764404296875
▁an 2.83984375
▁extreme 6.6328125
▁issue 3.474609375
▁among 3.251953125
▁at 9.375
▁least 0.09423828125
▁ 0.348388671875
8 3.80078125
% 1.837890625
▁of 0.050384521484375
▁the 0.7275390625
▁residents 7.52734375
▁of 0.364013671875
▁progress 12.078125
ive 0.12213134765625
▁countries 0.44775390625
. 0.453369140625
▁The 2.078125
▁introduction 6.95703125
▁of 0.014404296875
▁the 3.111328125
▁study 6.71875
▁describes 5.32421875
▁the 0.55810546875
▁apparent 9.1796875
▁link 3.7109375
▁between 0.08013916015625
▁pain 2.134765625
▁and 0.358642578125
▁dem 9.15625
oral 1.4599609375
ization 0.06976318359375
. 0.8271484375
▁Chron 4.58984375
ic 0.00878143310546875
▁pain 0.192138671875
▁is 1.5009765625
▁always 5.421875
▁accompanied 1.544921875
▁by 0.053802490234375
▁negative 3.892578125
▁emot 0.501953125
ional 1.169921875
▁experiences 3.173828125
▁and 2.50390625
▁blocks 11.4375
▁a 2.87890625
▁person 0.75537109375
’ 0.66259765625
s 0.0014362335205078125
▁ability 1.1796875
▁to 0.02301025390625
▁receive 6.49609375
▁joy 3.3515625
▁and 1.6748046875
▁satisfaction 2.353515625
▁from 0.701171875
▁life 0.822265625
. 0.225830078125
▁The 1.9384765625
▁research 2.76171875
▁investig 5.89453125
ates 0.30859375
▁the 0.5146484375
▁development 6.890625
▁of 0.053253173828125
▁de 1.0048828125
pression 0.1514892578125
▁and 0.264892578125
▁anx 0.048919677734375
iety 0.0004925727844238281
▁among 1.142578125
▁patients 0.9794921875
▁receiving 2.26171875
▁ph 3.09765625
arma 0.096923828125
ce 0.003082275390625
ut 1.6570091247558594e-05
ical 0.006038665771484375
▁op 0.69580078125
io 0.262939453125
ids 0.12548828125
▁and 0.7666015625
▁medical 1.177734375
▁mar 0.1038818359375
iju 0.0004916191101074219
ana 2.86102294921875e-05
▁( 2.810546875
MM 0.456298828125
) 1.2490234375
▁as 1.7734375
▁severe 10.3203125
▁pain 0.498046875
kill 2.56640625
ers 0.0002315044403076172
. 0.138427734375
▁It 2.98046875
▁comp 4.20703125
ares 0.006404876708984375
▁the 0.484130859375
▁effic 4.37109375
acy 0.00310516357421875
▁of 0.2132568359375
▁pres 6.453125
cri 2.5
ptions 0.82177734375
▁and 1.3818359375
▁exam 4.65625
ines 0.00708770751953125
▁the 0.59619140625
▁possibility 3.775390625
▁of 0.1256103515625
▁post 9.5
- 0.962890625
tre 1.578125
at 0.00186920166015625
ment 0.0032367706298828125
▁de 1.4560546875
pression 0.053802490234375
. 1.4248046875
<0x0A> 0.462890625
This 2.859375
▁type 6.28515625
▁of 0.004215240478515625
▁study 1.5166015625
▁is 0.87841796875
▁the 4.01171875
▁most 1.8759765625
▁reve 8.5390625
aling 0.000652313232421875
▁and 1.8291015625
▁inclus 6.8359375
ive 0.0007224082946777344
, 3.201171875
▁as 1.248046875
▁it 0.2216796875
▁contains 4.5859375
▁direct 6.109375
▁responses 6.66015625
▁from 0.6328125
▁a 3.669921875
▁large 1.171875
▁number 0.4970703125
▁of 0.0019016265869140625
▁participants 1.31640625
. 0.344970703125
▁All 5.2734375
▁tools 8.6796875
▁in 4.421875
▁the 0.9345703125
▁form 4.2734375
▁of 0.038299560546875
▁question 0.5576171875
na 0.0101318359375
ires 9.799003601074219e-05
▁and 1.2998046875
▁scales 2.837890625
▁have 3.171875
▁already 3.8828125
▁been 0.360595703125
▁used 2.3828125
▁and 1.8916015625
▁proved 2.3828125
▁their 1.2978515625
▁effic 3.03125
acy 0.004070281982421875
▁for 3.80859375
▁collect 3.72265625
ing 0.0018749237060546875
▁analyt 7.9296875
ical 0.1173095703125
▁data 0.1832275390625
. 0.318359375
▁It 3.162109375
▁helps 4.18359375
▁to 0.5439453125
▁system 6.8359375
at 0.4326171875
ize 0.0016498565673828125
▁and 1.47265625
▁class 4.62109375
ify 0.002040863037109375
▁distinct 8.5078125
▁kinds 6.1953125
▁of 0.01532745361328125
▁information 2.19140625
▁for 4.12890625
▁subsequent 5.25390625
▁un 8.65625
comp 4.5
licated 0.02008056640625
▁services 12.140625
. 0.5029296875
▁Thus 4.76171875
, 0.0035381317138671875
▁research 4.04296875
ers 0.53662109375
▁can 1.5078125
▁compare 2.625
▁the 1.009765625
▁effects 2.833984375
▁of 0.09759521484375
▁medic 3.63671875
ations 0.57080078125
▁on 1.630859375
▁patients 1.9921875
▁of 4.16015625
▁diverse 4.5078125
▁age 1.759765625
▁groups 2.21484375
, 0.8291015625
▁background 3.71484375
s 0.127685546875
, 0.02777099609375
▁physical 5.703125
▁conditions 1.55078125
, 0.041168212890625
▁emot 6.37890625
ional 0.03350830078125
▁states 1.3916015625
, 0.046722412109375
▁and 0.39990234375
▁so 2.6015625
▁on 0.2486572265625
. 0.056854248046875
<0x0A> 0.9140625
The 0.95458984375
▁study 1.9140625
▁was 2.619140625
▁conducted 0.5595703125
▁in 1.08203125
▁the 1.40234375
▁form 2.455078125
▁of 0.00160980224609375
▁collection 10.3046875
▁and 0.802734375
▁analysis 0.60693359375
▁of 0.0273590087890625
▁statistical 3.755859375
▁data 0.1451416015625
. 0.74755859375
▁Part 4.37890625
icip 0.09002685546875
ants 0.04119873046875
▁were 0.818359375
▁rec 3.826171875
ru 0.000751495361328125
ited 0.0001538991928100586
▁for 4.09375
▁six 6.34375
▁months 0.393798828125
▁at 3.931640625
▁two 2.68359375
▁major 3.767578125
▁pain 2.93359375
▁relief 3.705078125
▁cent 0.791015625
ers 0.0185546875
▁in 0.7578125
▁Israel 6.2265625
. 0.2841796875
▁The 1.4326171875
▁research 2.51953125
ers 1.17578125
▁used 2.314453125
▁The 7.8984375
▁De 3.009765625
pression 0.0212249755859375
▁Module 6.28515625
▁of 0.755859375
▁the 0.1995849609375
▁Pat 3.4296875
ient 0.0109100341796875
▁Health 0.0394287109375
▁Question 0.0184783935546875
naire 0.0229644775390625
▁and 2.5859375
▁the 0.84033203125
▁General 1.39453125
ized 0.7373046875
▁An 0.005649566650390625
x 8.90493392944336e-05
iety 0.0003674030303955078
▁Dis 0.09771728515625
order 0.0218353271484375
▁Sc 1.3349609375
ale 0.0015125274658203125
▁to 1.0302734375
▁interview 7.39453125
▁participants 2.9765625
, 4.41796875
▁evaluate 4.67578125
▁their 0.49609375
▁answers 3.5546875
, 0.1934814453125
▁and 0.0330810546875
▁conduct 5.1875
▁the 1.990234375
▁study 2.486328125
. 0.11077880859375
▁To 5.12890625
▁specifically 9.984375
▁evaluate 3.623046875
▁and 4.78515625
▁compare 0.61865234375
▁the 0.327880859375
▁prob 10.21875
abilities 0.0909423828125
▁of 0.0738525390625
▁de 0.95361328125
pression 0.0311737060546875
▁or 4.40234375
▁anx 0.04833984375
iety 0.0005621910095214844
▁among 1.595703125
▁the 2.28515625
▁diverse 8.6953125
▁groups 0.67626953125
, 0.7568359375
▁the 0.75830078125
▁study 2.9296875
▁used 1.3525390625
▁multiple 5.59375
▁log 1.1455078125
istic 0.0321044921875
▁regression 0.294921875
▁analysis 1.42578125
▁and 2.880859375
▁chose 8.5703125
▁medical 6.359375
▁mar 0.0614013671875
iju 0.0010776519775390625
ana 3.2901763916015625e-05
▁as 0.57763671875
▁the 0.892578125
▁control 2.736328125
▁group 0.646484375
. 0.2349853515625
<0x0A> 0.326416015625
The 0.7109375
▁analysis 3.72265625
▁of 0.91796875
▁any 9.625
▁human 6.953125
▁reaction 4.42578125
▁has 4.7578125
▁a 1.916015625
▁high 3.033203125
▁potential 3.2265625
▁of 1.9501953125
▁subject 2.935546875
iveness 3.66015625
▁and 1.267578125
▁bias 1.662109375
, 2.021484375
▁especially 2.087890625
▁regarding 3.6484375
▁people 5.21484375
▁in 3.689453125
▁severe 2.591796875
▁pain 0.67431640625
▁and 2.375
▁un 5.62109375
stable 1.0166015625
▁emot 0.57861328125
ional 0.0701904296875
▁condition 2.7421875
. 0.045501708984375
▁Perhaps 8.15625
▁some 5.203125
▁patients 1.9638671875
▁tend 5.04296875
▁to 0.0083770751953125
▁ex 2.048828125
agger 0.00931549072265625
ate 0.0014371871948242188
▁their 0.90673828125
▁de 3.154296875
press 1.791015625
ive 0.060028076171875
▁state 2.501953125
▁or 1.6650390625
▁vice 5.82421875
▁vers 0.025146484375
a 4.8279762268066406e-05
, 1.0712890625
▁de 7.28515625
- 2.431640625
emph 0.4384765625
as 0.0023441314697265625
ize 0.064208984375
▁serious 6.90625
▁difficulties 5.79296875
. 0.8154296875
▁Because 6.15234375
▁the 2.865234375
▁survey 5.12109375
▁responses 6.84375
▁were 1.3544921875
▁thoroughly 8.71875
▁anonymous 2.865234375
, 0.252685546875
▁the 1.2060546875
▁research 0.8671875
ers 0.1341552734375
▁were 2.6328125
▁unable 2.296875
▁to 0.0012073516845703125
▁carefully 7.6953125
▁analyze 2.703125
▁each 2.3671875
▁patient 2.3203125
’ 0.5625
s 0.0005435943603515625
▁reaction 3.98828125
▁and 1.3212890625
▁compare 3.5703125
▁it 0.8447265625
▁to 0.60595703125
▁the 0.9306640625
▁actual 4.5
▁states 7.83984375
▁of 0.74755859375
▁condition 6.80859375
. 0.3037109375
▁More 6.4375
▁accurate 3.1796875
▁answers 4.27734375
▁could 1.810546875
▁be 0.74072265625
▁obtained 1.0283203125
▁by 1.3671875
▁professional 6.11328125
▁psych 1.12109375
olog 0.376953125
ists 0.0011034011840820312
▁via 7.3203125
▁personal 2.666015625
▁communication 4.21875
▁and 2.029296875
▁behavior 6.28515625
al 0.26123046875
▁analysis 1.9267578125
. 0.2509765625
▁However 3.046875
, 0.00029778480529785156
▁this 1.4365234375
▁method 2.21484375
▁of 2.7421875
▁research 1.8447265625
▁is 1.1201171875
▁way 5.68359375
▁more 0.8193359375
▁resource 4.73828125
- 0.265869140625
int 1.44140625
ensive 0.0253143310546875
▁and 0.400634765625
▁energy 10.8125
- 0.07110595703125
consum 0.36962890625
ing 0.0018482208251953125
. 0.71533203125
<0x0A> 0.372802734375
Part 5.79296875
icip 0.1708984375
ants 0.1053466796875
▁were 1.189453125
▁rec 2.388671875
ru 0.0007224082946777344
ited 3.4928321838378906e-05
▁for 1.794921875
▁six 0.377197265625
▁months 0.006435394287109375
▁at 0.3671875
▁two 0.0694580078125
▁major 0.0950927734375
▁pain 0.035430908203125
▁relief 0.0203399658203125
▁cent 0.010528564453125
ers 0.0007619857788085938
▁in 0.0382080078125
▁Israel 0.00949859619140625
. 0.18212890625
▁All 4.39453125
▁patients 1.7509765625
▁experienced 4.3984375
▁chron 0.81884765625
ic 0.00016951560974121094
▁pain 0.190185546875
▁for 2.1875
▁at 0.6220703125
▁least 0.0015869140625
▁ 1.845703125
3 1.5390625
▁months 0.24853515625
. 1.267578125
▁The 1.3720703125
▁study 1.7138671875
▁included 1.5693359375
▁ 0.5615234375
8 3.0390625
9 2.470703125
0 2.916015625
▁participants 1.59765625
, 1.35546875
▁of 2.845703125
▁which 0.397705078125
▁ 0.099365234375
4 1.2685546875
7 2.615234375
4 2.603515625
▁( 3.31640625
5 0.09930419921875
9 4.875
%) 0.68798828125
▁were 0.958984375
▁treated 2.923828125
▁sole 6.921875
ly 0.00015652179718017578
▁with 0.303955078125
▁op 1.1474609375
io 0.33203125
ids 0.1473388671875
, 0.55029296875
▁ 0.93994140625
3 1.2197265625
2 2.259765625
9 2.462890625
▁( 0.046539306640625
4 2.541015625
1 1.3193359375
%) 0.0550537109375
▁were 1.5673828125
▁treated 0.61865234375
▁with 0.361328125
▁MM 0.71630859375
, 0.323486328125
▁and 0.1014404296875
▁ 0.2294921875
7 1.998046875
7 2.431640625
▁( 0.11920166015625
8 1.9072265625
. 0.8876953125
6 2.31640625
%) 0.065673828125
▁acquired 10.234375
▁both 0.599609375
▁( 5.12890625
Fe 9.515625
ing 1.2373046875
old 0.410888671875
▁et 0.9541015625
▁al 0.0197601318359375
., 0.1849365234375
▁ 0.01522064208984375
2 0.006862640380859375
0 0.0004680156707763672
1 0.2022705078125
7 1.6416015625
). 0.04754638671875
▁The 1.146484375
▁remaining 7.48046875
▁ten 6.73046875
▁participants 1.3115234375
▁who 4.90234375
▁did 2.388671875
▁not 0.00604248046875
▁receive 2.078125
▁ph 4.18359375
arma 0.10809326171875
ce 0.0008997917175292969
ut 2.1457672119140625e-06
ical 0.0026950836181640625
▁op 2.271484375
io 0.07855224609375
ids 0.026153564453125
▁and 2.6015625
▁medical 2.05078125
▁mar 0.037445068359375
iju 0.0003020763397216797
ana 3.0159950256347656e-05
▁were 0.47119140625
▁with 6.70703125
dra 0.05352783203125
wn 2.765655517578125e-05
▁from 0.236572265625
▁the 0.1849365234375
▁analysis 2.267578125
▁in 5.1875
▁the 1.056640625
▁research 4.36328125
. 0.9912109375
▁Therefore 5.09375
, 0.00766754150390625
▁it 3.82421875
▁is 1.37890625
▁not 2.962890625
▁possible 0.69482421875
▁to 0.00467681884765625
▁compreh 5.9296875
ens 0.13916015625
ively 0.0155029296875
▁compare 1.166015625
▁patients 5.0859375
▁taking 3.98828125
▁medic 4.16015625
ations 0.469970703125
▁with 1.44140625
▁those 1.046875
▁who 0.7705078125
▁do 1.7041015625
▁not 0.004283905029296875
. 0.57763671875
<0x0A> 0.591796875
The 0.83154296875
▁question 4.859375
na 0.5068359375
ires 4.208087921142578e-05
▁used 2.041015625
▁different 8.109375
▁variable 9.46875
▁measures 4.4140625
▁to 1.3740234375
▁collect 2.876953125
▁information 1.5615234375
. 1.25
▁For 2.267578125
▁example 0.54541015625
, 0.002410888671875
▁it 4.5078125
▁included 1.50390625
▁compreh 8.828125
ensive 0.0589599609375
▁so 5.83984375
cio 0.0018167495727539062
- 0.2359619140625
dem 0.10479736328125
ographic 0.0694580078125
▁data 0.91015625
: 4.52734375
▁gender 2.07421875
, 0.0498046875
▁age 0.2037353515625
, 0.0389404296875
▁country 4.19140625
, 2.34765625
▁type 4.3125
▁of 0.0709228515625
▁residence 4.1796875
▁( 2.388671875
urban 0.80908203125
/ 1.4326171875
r 0.1602783203125
ural 0.0010166168212890625
), 0.1639404296875
▁years 6.1328125
▁of 0.1480712890625
▁education 0.6240234375
, 0.093994140625
▁and 1.328125
▁employ 2.5546875
ment 0.001766204833984375
▁status 0.71142578125
. 0.1905517578125
▁Pat 4.62109375
ients 0.09527587890625
▁were 1.0556640625
▁also 0.73974609375
▁asked 0.5634765625
▁about 0.90625
▁their 0.689453125
▁medical 2.626953125
▁history 0.50439453125
▁over 8.71875
▁the 0.060577392578125
▁years 4.65234375
▁and 1.724609375
▁the 1.5390625
▁current 3.068359375
▁presence 5.02734375
▁of 0.07672119140625
▁any 2.046875
▁severe 3.59765625
▁dise 1.951171875
ases 8.440017700195312e-05
▁such 4.3671875
▁as 0.0011615753173828125
▁heart 2.5859375
▁failure 1.6796875
, 0.278564453125
▁di 1.5927734375
ab 0.0007777214050292969
etes 0.0020961761474609375
, 0.0648193359375
▁ar 4.234375
th 0.17236328125
rit 0.026397705078125
is 0.00418853759765625
, 0.0245208740234375
▁and 1.2490234375
▁so 0.8603515625
▁on 0.065673828125
. 0.05499267578125
▁The 1.6064453125
▁third 6.67578125
▁measure 4.44921875
▁of 2.220703125
▁the 0.89697265625
▁question 1.2060546875
naire 0.208984375
▁was 1.076171875
▁indicated 10.9765625
▁by 1.3974609375
▁information 6.98046875
▁on 2.064453125
▁any 5.39453125
▁twelve 14.0625
- 0.232421875
month 0.167724609375
▁and 4.85546875
▁lifetime 0.81982421875
▁drug 3.41015625
▁and 1.8017578125
▁alco 0.1298828125
hol 6.175041198730469e-05
▁consumption 4.171875
. 0.453369140625
▁In 3.763671875
▁addition 0.81396484375
, 0.198974609375
▁the 1.0185546875
▁record 10.109375
▁included 1.26953125
▁a 2.744140625
▁pain 4.3125
▁measurement 4.9296875
▁scale 0.83203125
▁from 3.96875
▁ 0.43212890625
0 0.301025390625
▁to 0.2332763671875
▁ 0.005615234375
1 0.0709228515625
0 0.0347900390625
▁to 3.2578125
▁evaluate 1.669921875
▁dis 5.953125
com 0.095458984375
fort 0.0018281936645507812
▁feelings 8.2421875
▁during 3.98046875
▁the 0.27001953125
▁last 1.0703125
▁month 1.7451171875
. 0.255615234375
<0x0A> 0.408447265625
The 0.830078125
▁study 1.990234375
▁conducted 4.109375
▁a 1.3369140625
▁correlation 6.01953125
▁type 9.3359375
▁of 0.1856689453125
▁research 1.3779296875
▁with 3.232421875
▁variable 7.87109375
▁measures 0.990234375
. 1.0302734375
▁It 1.4775390625
▁evaluated 4.6015625
▁the 0.63671875
▁inter 5.9609375
dep 2.375
end 0.00018346309661865234
ence 0.00952911376953125
▁of 0.60009765625
▁various 3.052734375
▁factors 0.841796875
▁that 2.822265625
▁affected 3.748046875
▁the 0.478759765625
▁physical 6.28125
▁and 0.27392578125
▁emot 0.48388671875
ional 9.21487808227539e-05
▁condition 1.3720703125
▁of 0.0494384765625
▁patients 0.6884765625
▁experien 3.185546875
cing 2.2649765014648438e-06
▁chron 0.2734375
ic 0.00014340877532958984
▁pain 0.01348114013671875
. 0.100830078125
▁For 3.1328125
▁example 0.4033203125
, 0.0007233619689941406
▁the 1.1220703125
▁survey 4.6328125
▁showed 3.8671875
▁that 0.45458984375
▁the 2.001953125
▁ratio 7.09375
▁of 0.08685302734375
▁female 2.630859375
▁patients 0.87646484375
▁was 0.99609375
▁remark 8.1328125
ably 0.0001710653305053711
▁higher 0.1688232421875
▁in 2.734375
▁the 0.587890625
▁op 3.31640625
i 2.791015625
ates 0.01224517822265625
▁group 0.212890625
▁compared 2.3203125
▁to 0.043182373046875
▁the 0.68505859375
▁MM 0.1839599609375
▁group 0.52978515625
. 0.493408203125
▁In 3.09765625
▁turn 4.19140625
, 0.0007796287536621094
▁people 4.24609375
▁on 5.40625
▁op 2.912109375
i 0.64697265625
ates 0.004787445068359375
▁were 0.828125
▁more 1.3779296875
▁likely 0.1964111328125
▁to 0.02532958984375
▁report 3.439453125
▁major 6.4765625
▁de 1.1396484375
press 0.7763671875
ive 0.002819061279296875
▁dis 0.98095703125
orders 1.3837890625
. 2.0703125
<0x0A> 2.4375
Am 5.671875
ong 0.0032901763916015625
▁all 2.203125
▁participants 1.7373046875
▁in 3.2578125
▁the 0.20703125
▁study 0.72705078125
, 0.049285888671875
▁ 1.10546875
4 1.9677734375
2 2.357421875
. 1.0390625
2 2.2265625
% 0.059112548828125
▁suffered 3.591796875
▁from 0.051513671875
▁de 1.14453125
pression 0.1683349609375
, 1.060546875
▁and 1.130859375
▁ 0.26318359375
3 1.447265625
7 2.37890625
% 2.5234375
▁experienced 2.14453125
▁excess 6.67578125
ive 0.0302581787109375
▁anx 0.1964111328125
iety 0.001953125
. 0.3310546875
▁The 1.556640625
▁pl 10.9921875
ur 0.66845703125
ality 0.0007534027099609375
▁of 0.10406494140625
▁de 2.466796875
press 1.2587890625
ive 0.034271240234375
▁dis 2.494140625
orders 0.06341552734375
▁among 2.9296875
▁patients 1.076171875
▁in 2.857421875
▁the 0.327880859375
▁op 0.57958984375
i 0.28564453125
ates 0.0018701553344726562
, 9.5234375
▁medical 4.0390625
▁mar 0.0254364013671875
iju 0.0007762908935546875
ana 2.6226043701171875e-05
, 0.1785888671875
▁and 0.10467529296875
▁mixed 1.5185546875
▁OP 11.8125
MM 4.90234375
▁groups 0.55810546875
▁number 9.4765625
ed 0.01617431640625
▁ 0.16650390625
5 1.873046875
7 2.671875
. 0.517578125
1 2.501953125
%, 0.1925048828125
▁ 0.0027713775634765625
2 1.9248046875
2 2.615234375
. 0.1092529296875
3 2.26171875
%, 0.048309326171875
▁and 0.05303955078125
▁ 0.0016469955444335938
5 2.220703125
1 2.0546875
. 0.16650390625
4 1.828125
%, 0.155517578125
▁respectively 0.02203369140625
. 0.2003173828125
▁The 1.3212890625
▁pl 3.869140625
ur 0.0104827880859375
ality 3.218650817871094e-05
▁of 0.023468017578125
▁anx 0.447265625
iety 0.01910400390625
▁contained 10.65625
▁ 0.1876220703125
4 1.1474609375
8 2.3203125
. 0.173828125
4 2.193359375
% 2.064453125
▁among 2.576171875
▁OP 4.7890625
▁patients 6.234375
, 0.286376953125
▁ 0.0828857421875
2 0.91064453125
1 2.478515625
. 0.11474609375
5 2.134765625
% 0.02520751953125
▁among 0.49267578125
▁MM 0.09783935546875
▁patients 0.412841796875
, 0.01551055908203125
▁and 0.01434326171875
▁ 0.027862548828125
3 1.3837890625
8 1.9052734375
. 0.1240234375
7 2.21484375
% 0.010955810546875
▁among 0.2001953125
▁OP 2.525390625
MM 0.1781005859375
▁participants 3.17578125
. 0.188232421875
▁Pat 5.26953125
ients 0.0176849365234375
▁who 1.9833984375
▁took 2.3359375
▁strong 9.8671875
▁op 0.75390625
i 0.78076171875
ates 0.003383636474609375
▁were 1.2041015625
▁t 10.265625
ended 1.0146484375
▁to 0.006908416748046875
▁place 9.8046875
▁their 2.048828125
▁pain 1.23828125
▁on 1.8896484375
▁a 0.58154296875
▁scale 1.712890625
▁of 0.35595703125
▁ 0.09844970703125
9 2.626953125
▁to 2.275390625
▁ 0.010894775390625
1 0.004711151123046875
0 0.005321502685546875
▁( 2.927734375
Fe 1.703125
ing 0.002323150634765625
old 0.0004439353942871094
▁et 0.01186370849609375
▁al 0.0016613006591796875
., 0.010162353515625
▁ 0.0011777877807617188
2 0.0001704692840576172
0 3.4689903259277344e-05
1 0.0009632110595703125
7 0.005615234375
). 0.009765625
▁They 4.37109375
▁were 1.638671875
▁also 0.83935546875
▁an 9.5625
gu 4.83203125
ished 0.08270263671875
▁em 6.33203125
otion 0.0009217262268066406
ally 0.0007114410400390625
▁and 0.99169921875
▁react 7.49609375
ed 0.0211639404296875
▁rad 9.0390625
ically 0.0014743804931640625
▁neg 4.94921875
atively 0.0011987686157226562
▁to 0.1727294921875
▁almost 5.6875
▁all 1.52734375
▁survey 3.818359375
▁questions 0.2822265625
. 0.294921875
▁Pat 4.26953125
ients 0.00458526611328125
▁who 1.2734375
▁took 1.7119140625
▁only 4.421875
▁MM 0.3623046875
▁or 2.59375
▁mixed 2.298828125
▁medic 1.2705078125
ations 0.2083740234375
▁course 13.8828125
▁had 2.509765625
▁a 1.4638671875
▁significantly 2.873046875
▁more 2.958984375
▁stable 2.501953125
▁emot 0.8681640625
ional 0.0009579658508300781
▁state 0.51708984375
▁and 1.103515625
▁cop 6.62890625
ed 0.023712158203125
▁with 0.322998046875
▁pain 0.8291015625
▁more 1.806640625
▁manage 6.51171875
able 1.302734375
. 0.2462158203125
<0x0A> 0.1549072265625
One 4.875
▁of 0.1966552734375
▁the 0.0027980804443359375
▁major 2.8515625
▁limitations 2.5859375
▁is 3.025390625
▁the 0.46484375
▁ins 4.64453125
u 0.07110595703125
fficient 0.07794189453125
ly 3.5
▁high 3.072265625
▁response 3.34765625
▁rate 0.10443115234375
, 2.75390625
▁ 4.69140625
5 1.6123046875
7 2.837890625
% 2.35546875
▁instead 6.41015625
▁of 0.002468109130859375
▁ 0.4814453125
7 1.8310546875
0 0.431884765625
% 1.4365234375
▁( 2.412109375
Fe 0.658203125
ing 0.0018758773803710938
old 0.0003046989440917969
▁et 0.00899505615234375
▁al 0.00025010108947753906
., 0.006847381591796875
▁ 0.0009851455688476562
2 0.0001043081283569336
0 7.140636444091797e-05
1 0.00036072731018066406
7 0.003597259521484375
). 0.01001739501953125
▁It 1.7041015625
▁can 3.099609375
▁be 0.7880859375
▁fairly 8.28125
▁explained 1.6025390625
▁by 0.1962890625
▁the 0.277587890625
▁weak 7.40234375
▁focus 7.05078125
▁of 0.6787109375
▁respond 5.5546875
ents 0.11474609375
▁who 3.443359375
▁have 3.908203125
▁overcome 8.28125
▁severe 2.048828125
▁pain 0.53662109375
▁sens 7.72265625
ations 0.19775390625
▁and 0.92724609375
▁de 4.72265625
press 0.80029296875
ive 0.05023193359375
▁episodes 2.1640625
. 0.489501953125
▁It 2.7734375
▁is 0.7451171875
▁not 2.55859375
▁clear 3.58203125
▁how 1.923828125
▁to 3.533203125
▁use 5.30078125
▁these 2.75390625
▁statistics 3.88671875
, 3.0546875
▁as 0.599609375
▁they 1.943359375
▁still 5.1171875
▁may 4.921875
▁be 1.2470703125
▁relevant 6.10546875
▁for 1.6318359375
▁the 1.89453125
▁overall 4.6953125
▁analysis 2.87890625
. 0.9111328125
